CAS 1467057-23-3

Formel: C19H16ClNO3

InChl: InChI=1S/C19H16ClNO3/c20-16-9-17-14(15(10-21-17)18(22)23)8-13(16)11-2-4-12(5-3-11)19(24)6-1-7-19/h2-5,8-10,21,24H,1,6-7H2,(H,22,23)

InChI Key: FHQXLWCFSUSXBF-UHFFFAOYSA-N

SMILES: C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=C3)C(=CN4)C(=O)O)Cl)O

PF-06409577

CAS: 1467057-23-3

PF-06409577

Formel: C₁₉H₁₆ClNO₃

Reinheit: 98%

Molekulargewicht: 341.79

Ref: 54-OR1022924

PF-06409577

CAS: 1467057-23-3

PF-06409577

Formel: C₁₉H₁₆ClNO₃

Reinheit: 98.5%

Molekulargewicht: 341.79

Ref: 54-BUP13142

PF-06409577

CAS: 1467057-23-3

PF-06409577 is an effective, orally active, and specific allosteric activator of AMPK (EC50: 7 nM, for α1β1γ1).

Formel: C₁₉H₁₆ClNO₃

Reinheit: 98.21% - 98.89%

Farbe und Form: Solid

Molekulargewicht: 341.788

Ref: TM-T4427

6-Chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylic acid

CAS: 1467057-23-3

6-Chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylic acid

Formel: C₁₉H₁₆ClNO₃

Reinheit: 98%

Molekulargewicht: 341.79

Ref: IN-DG758851

PF-06409577

CAS: 1467057-23-3

Formel: C₁₉H₁₆ClNO₃

Molekulargewicht: 341.79

Ref: 4Z-P-476001

PF 06409577

CAS: 1467057-23-3

Potent agonist of a1β1γ1 5′-adenosine monophosphate-activated protein kinase (AMPK). It binds to the allosteric drug and metabolite (ADaM) site at the α- and β- subunit interface of AMPK. It has potential for the treatment of diabetic nephropathy. PF 06409577 reduces infections caused by flaviviruses, mediated by changes in the metabolism of lipids in host cells.

Formel: C₁₉H₁₆ClNO₃

Reinheit: Min. 95%

Farbe und Form: White/Off-White Solid

Molekulargewicht: 341.79 g/mol

Ref: 3D-BP166583

6-CHLORO-5-(4-(1-HYDROXYCYCLOBUTYL)PHENYL)-1H-INDOLE-3-CARBOXYLIC ACID

CAS: 1467057-23-3

Formel: C₁₉H₁₆ClNO₃

Reinheit: 98%

Molekulargewicht: 341.79

Ref: 10-F532134

1H-​Indole-​3-​carboxylic acid, 6-​chloro-​5-​[4-​(1-​hydroxycyclobutyl)​phenyl]​-

CAS: 1467057-23-3

Formel: C₁₉H₁₆ClNO₃

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 341.7882

Ref: IN-DA001E8X